First human test of eczema pill halted early
Disease control
Terminated
This was an early-stage study to check the safety of a new oral medication called IPG7236, intended for atopic dermatitis (eczema). It tested single and multiple doses in 63 healthy adults to see how the body processes the drug and if food affects it. The trial was terminated, me…
Phase: PHASE1 • Sponsor: Nanjing Immunophage Biotech Co., Ltd • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC